Items Tagged ‘Biomarker Discovery’
January 23, 2018
A new way of capturing the molecular alterations of cancer
Mayo Clinic researchers have a new way of plotting how cancer has progressed deep within a patient’s genetic blueprint. It’s a new graphing method called the Genome U-plot that reveals genetic changes taking place on a molecular level. The Genome U-plot’s two-dimensional layout and high spacial resolution make it possible to show chromosomal deletions, breaks, […]
Tags: Biomarker Discovery, cancer, Dr. George Vasmatzis, Genetics, genomic medicine, genomics, mayo clinic, Mayo Clinic Center for Individualized Medicine
March 3, 2016
Individualizing Medicine Conference 2016: Mark Your Calendars for October 5-6
By Jeff Briggs 
Time off, travel plans, hotel reservations. These things don’t happen at the last minute. If you’re interested in genomic medicine and how precision medicine is being applied in health care today, you should be planning now to join us at Mayo Clinic in Rochester, Minn., for the 2016 Individualizing Medicine Conference. The dates are October […]
Tags: #CIMCon2016, Biomarker Discovery, cancer, center for individualized medicine, DNA Sequencing, Epigenomics, genomic medicine, individualized medicine, individualizing medicine conference, individualizing medicine conference 2016, microbiome, pharmacogenomics
January 14, 2014
Pursuing Future Ventures in Biomarker Discovery
By Sam Smith
Five business students from around the state have immersed themselves in our Biomarker Discovery Program where they are conducting commercial assessments of Mayo Clinic discoveries in cancer diagnostics. These students, who work with the Center for Individualized Medicine and Mayo Clinic Ventures, conduct a semester-long evaluation of molecular discoveries that could help oncologists better diagnose […]
Tags: biomarker, Biomarker Discovery, biomarkers, cancer, Cancer Research, individualized medicine, lymphoma, mayo clinic, Mayo Clinic Ventures, oncology, personalized care, personalized medicine
November 21, 2013
ASCL1 And RET Expression Defines Clinically Relevant Subgroup Of Lung Adenocarcinoma
By Center for Individualized Medicine
A recent publication, featuring the Director of the Biomarker Discovery Program at the Center for Individualized Medicine at Mayo Clinic, George Vasmatzis, examining the role of ASCL1 in the neuroendocrine differentiation of lung adenocarcinoma. The clinical significance of neuroendocrine differentiation in lung adenocarcinoma, and the most appropriate biomarkers for this assessment, has long been debated. In the […]
Tags: ASCL1, biomarker, Biomarker Discovery, Biomarker Discovery Program, cancer, center for individualized medicine, chromogranin, DNA, George Vasmatzis, immunohistochemical, individualized medicine, Lung Cancer